HSBC Holdings
VIR icon

HSBC Holdings’s Vir Biotechnology VIR Stock Holding History

HSBC Holdings’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,736
Closed -$249K – 3238
2026
Q1 		$249K Sell
27,736
-3,174
-10% -$25.3K ﹤0.01% 2526
2025
Q4 		$182K Sell
30,910
-26,685
-46% -$159K ﹤0.01% 2706
2025
Q3 		$323K Buy
57,595
+13,269
+30% +$67.8K ﹤0.01% 2302
2025
Q2 		$229K Buy
44,326
+30,077
+211% +$161K ﹤0.01% 2613
2025
Q1 		$91.1K Sell
14,249
-12,060
-46% -$107K ﹤0.01% 2824
2024
Q4 		$192K Buy
+26,309
New +$208K ﹤0.01% 2732
2024
Q3 		– Sell
-46,222
Closed -$405K – 3168
2024
Q2 		$405K Buy
46,222
+27,605
+148% +$265K ﹤0.01% 2096
2024
Q1 		$189K Sell
18,617
-3,109
-14% -$31.7K ﹤0.01% 2707
2023
Q4 		$219K Buy
21,726
+5,655
+35% +$51.7K ﹤0.01% 2429
2023
Q3 		$151K Buy
+16,071
New +$229K ﹤0.01% 2485
2022
Q4 		– Sell
-13,776
Closed -$270K – 3200
2022
Q3 		$270K Sell
13,776
-2,696
-16% -$68.5K ﹤0.01% 2472
2022
Q2 		$422K Buy
+16,472
New +$385K ﹤0.01% 2435
2022
Q1 		– Sell
-8,634
Closed -$362K – 3502
2021
Q4 		$362K Buy
+8,634
New +$338K ﹤0.01% 2655

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings's VIR Position: Q2 2026 in Review

HSBC Holdings sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 27,736 shares — an estimated $249K sold.

HSBC Holdings first reported a position in VIR in Q4 2021 and held it in 13 quarters. The position peaked at $422K in Q2 2022. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • HSBC Holdings reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 27,736 Vir Biotechnology shares in Q2 2026, an estimated $249K.
  • HSBC Holdings first reported a position in Vir Biotechnology in Q4 2021 and held it in 13 quarters.
  • HSBC Holdings's Vir Biotechnology position peaked at $422K in Q2 2022.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.